Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Joe who wrote (2677)	7/12/1999 10:39:00 PM
From: bob beck	Respond to of 4140

Joe: Don't remember seeing this article posted last week. First time sturza has been mentioned in a news article. Some very interesting facts come out: Ed promoting the company to institutional investors last week and the idiots from sturza blowing it out of their assholes. Its a shame there's no legal recourse against this type of slander: \| Home \| Register! \| Community \| My Bull \| Login \| Logout \| RT Quotes \| Sunrise Tech. Int'l (SNRS) Message List Real Time Quote Chart Free E-Mail Raging SNRS Links < Previous Respond Next > By: huckhound22 Reply To: 8205 by bearmeateater Monday, 12 Jul 1999 at 8:19 PM EDT Post # of 8217 Bearmeateater, WSJ article on SNRS..."July 8, 1999 Dow Jones Newswires Sunrise Tech Up 13% In Anticipation Of FDA Panel Review NEW YORK -- Sunrise Technologies International Inc. (SNRS) shares rose 14% Thursday in anticipation of a Food and Drug Administration-appointed panel review of the company's Laser Thermal Keratoplasty product set for July 22. Shares of the Fremont, Calif., company closed up 2 5/16 at 18 13/16 on volume of 5.5 million shares. The volume, which compares with an average turnover of 855,200 shares, was marked by heavy institutional activity. Sunrise Vice President of Corporate Communications Ed Coghlan said the LTK device meets or exceeds the FDA's requirements. The product, which treats hyperopia, or farsightedness, has received European marketing approval. Sunrise has been promoting itself at informational meetings with institutional investors this week, Coghlan said. According to the company spokesman, Sunrise's primary focus at this time is to receive FDA-approval for the device and then begin marketing the product to ophthalmologists, who can perform the five-minute procedure in their offices with an immediate effect. Still, Sturza's Medical Research analyst Stephen Sabba remains critical of the device, noting that the low levels of hyperopia that it has treated in its studies. He maintains the narrow range of diopters that the device can treat won't produce a significant demand for the product. In mid-June, negative analyst reports on the LTK device sent Sunrise shares tumbling and prompted the company to post a challenge to the analysts' research on its Web site. The growth of the laser refractive surgery market has spurred investors to seek "the next Visx," said Sabba, referring to Visx Inc. (VISX), a leader in the excimer refractive surgical market. The analyst doesn't believe Sunrise Technologies will be it. Visx shares closed Thursday up 5.7% at 93. Shares of Keravision, another Fremont, Calif. company focused on correcting vision problems, gained 17.1%, or 4 1/4, at 29 1/8 on heavy volume. The company has been trending upward since it reported it would post higher-than-expected earnings - Christina Cheddar; 201-938-5400 BoardMark MemberMark Ignore Poster Report TOS Violation SNRS Update Last 18 1/2 Chg. - 1/4 % -1.33% Time 15:59 Detailed \| Real-Time Nasdaq delayed 15 minutes, 20 min. otherwise. Your $0.02 Wanted! Why just lurk? Get in the ring. Click Here Previous \| Next \| Post New \| Respond \| View Replies Favorite Boardmarks \| IREG \| LCAV \| SNRS -------------------------------------------------------------------------------- Message Board Search Symbol Subject Member Board Directory Computer-Related General Boards Internet-Related Members' Corner Miscellaneous Non-Technology OTC BB Technology Telecommunications The Bull Pub The Writers' Guild Under $4 -------------------------------------------------------------------------------- Home \| Community \| Free Email \| My Bull \| Login \| Logout \| RT Quotes \| Copyright 1997-99 Raging Bull, Inc. All Rights Reserved Terms and Conditions